Licitación para software de análisis genético

Título oficial

The purpose of this contract is to purchase one licence of a program that integrates visualization, interpretation, in silico predictors including protein and splicing effects, database management of genetic variants obtained both by Sanger sequencing and massively sequencing which is absolutely necessary for the research activity based on the project “PI22/01200 Whole genome sequencing as a first-tier test to improve hereditary breast/ovarian genetic diagnosis” awarded to the Hereditary Cancer Genetics Group a research group of the accredited IIS center of the Fundació Hospital Universitari Vall Hebron – Institut de Recerca (VHIR). This project is financed by Instituto de Salud Carlos III (ISCIII) and co-financed by the European Union.